Suchergebnisse - "Sun, Chaoyang"

PubPharm (163)

101

COMBINATION OF PARP INHIBITOR AND BRD4 INHIBITOR FOR THE TREATMENT OF CANCER

enthalten in: Europäisches Patentamt | 2020

von MILLS GORDON | SUN CHAOYANG

102

Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer

enthalten in: Cancer cell | 2020

von McGrail, D. | Garnett, J. | Yin, J. | +20

CommentIn: Cancer Discov. 2020 May;10(5):OF11. - PMID 32144094

103

Correction to : A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients

enthalten in: BMC cancer | 2020

von Sun, C. | Guo, E. | Zhou, B. | +13

ErratumFor: BMC Cancer. 2019 Nov 8;19(1):1061. - PMID 31703584

104

Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients

enthalten in: BMC cancer | 2020

von Sun, C. | Guo, E. | Zhou, B. | +13

105

Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients

enthalten in: BMC cancer | 2020

von Sun, C. | Guo, E. | Zhou, B. | +13

106

WEE1 inhibitor, AZD1775, overcomes trastuzumab resistance by targeting cancer stem-like properties in HER2-positive breast cancer

enthalten in: Cancer letters | 2020

von Sand, A. | Piacsek, M. | Donohoe, D. | +7

107

MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis

enthalten in: Oncogene | 2020

von Sun, C. | Li, X. | Guo, E. | +16

108

Corrigendum to "Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer" [Cancer Lett 415 (20-29)

enthalten in: Cancer letters | 2020

von Yang, Z. | Jin, P. | Xu, S. | +8

ErratumFor: Cancer Lett. 2018 Feb 28;415:20-29. - PMID 29199004

109

BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages

enthalten in: Frontiers in immunology | 2020

von Li, X. | Fu, Y. | Yang, B. | +10

110

mTOR inhibition overcomes primary and acquired resistance to Wee1 inhibition by augmenting replication stress in epithelial ovarian cancers

enthalten in: American journal of cancer research | 2020

von Li, F. | Guo, E. | Huang, J. | +15